Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Over-the-counter medicine · no prescription needed

Brimonidine

Purpose on the label: Redness reliever

Eye care

Official FDA data, not advice

The label text is quoted exactly as the company filed it with the U.S. Food and Drug Administration (FDA), with a link to the official copy. The list of brands comes from the FDA NDC Directory.

This page is not medical advice. Read the label on your package, and ask a pharmacist or doctor if you are not sure a medicine is right for you, for your child, or with your other medicines.

If someone may have taken too much, call Poison Help: 1‑800‑222‑1222. In an emergency, call 911.

Quick answers

What is Brimonidine used for?
The Drug Facts label of LUMIFY Redness Reliever Eye Drops (Bausch & Lomb Incorporated) lists these uses: relieves redness of the eye due to minor eye irritations.
Do I need a prescription for Brimonidine?
No, the products on this page are sold without a prescription. Other products with the same active ingredient need a prescription (often a higher strength or another form): see the prescription page.
Is a store brand the same as the name brand?
Products listed together below have the same active ingredient, in the same amount and the same form, as registered with the FDA. Inactive ingredients (such as colors, flavors and fillers) and package sizes can differ. Compare the “Active ingredient” box on both packages, and ask a pharmacist if you are not sure.
Has Brimonidine been recalled?
No recall linked to these products appears in the FDA enforcement reports we use.

Also sold by prescription (often at a higher strength or in another form): Brimonidine tartrate — prescription medicine

Drug Facts label

Every over-the-counter medicine must carry a “Drug Facts” box in the same order, set by FDA rules. Below is the label of one product for each common strength and form, quoted word for word. Your own package can differ (for example, children’s products have other directions): always follow the label on your package.

LUMIFY Redness Reliever Eye Drops · Bausch & Lomb Incorporated

Brimonidine tartrate 0.25 mg/mL, solution/ drops (ophthalmic)

Active ingredient

Brimonidine tartrate (0.025%)

Purpose

Redness reliever

Uses

relieves redness of the eye due to minor eye irritations

Warnings

For external use only

Do not use

if solution changes color or becomes cloudy

Stop use and ask a doctor if

you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days

If pregnant or breast-feeding

ask a health professional before use.

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch tip of container to any surface replace cap after each use children under 5 years of age: consult a doctor

Inactive ingredients

benzalkonium chloride, boric acid, calcium chloride dihydrate, glycerin, potassium chloride, sodium borate decahydrate, sodium chloride, water for injection. Hydrochloric acid and/or sodium hydroxide may be used to adjust pH.

Questions?

[phone icon] Call: 1-800-553-5340

— FDA label of LUMIFY Redness Reliever Eye Drops, Bausch & Lomb Incorporated, effective March 31, 2026. See the official label on DailyMed →

This page is not medical advice. Read the label on your package, and ask a pharmacist or doctor if you are not sure a medicine is right for you, for your child, or with your other medicines.

Same medicine, other brands

Each group lists the products that have exactly the same active ingredient, in the same amount and form, as registered with the FDA (NDC Directory). A store brand in the same group has the same medicine as the name brand; inactive ingredients, flavors and package sizes can differ. Each product links to its own official label.

Brimonidine tartrate 0.25 mg/mL · solution/ drops (ophthalmic) · 2 products

Drug Facts for this strength and form ↑

Brand or product nameCompany on the labelLabel
Lumify Preservative Free Eye Drops Bausch & Lomb Incorporated DailyMed
LUMIFY Redness Reliever Eye Drops Bausch & Lomb Incorporated DailyMed

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Brimonidine, by strength and form
Strength and formGeneric or brandPharmacies pay
brimonidine tartrate 0.25 mg/mL
solution/ drops
Brand: LUMIFY Redness Reliever Eye Drops $2.00–$3.41 per mL
2 packages, lowest to highest

NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that sell this medicine

The company named on the package (maker or distributor), as listed in the FDA NDC Directory, with its number of over-the-counter products of this medicine.

Recalls

No recall linked to these products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  4. FDA rule for the Drug Facts label (21 CFR 201.66)

Only medicines marketed under FDA rules for nonprescription drugs (an FDA monograph or an FDA approval) are listed. Homeopathic products are not listed: the FDA does not evaluate them for safety or effectiveness.

Report an error → · Information for medicine makers